The MSDD degree program offers individuals already working in the industry with an opportunity to acquire advanced training in research activity as conducted and required by the US Food and Drug Administration (US FDA) and by other regulatory agencies.
In the US, the Bureau of Labor Statistics (BLS) predicts that the medical scientists’ workforce will grow by 8% from 2018 to 2028 – faster than the average for all occupations in the US. Further, medical scientists will continue to be needed as they contribute to the development of treatments and medicines that improve human health.
For clinical laboratory technologists and technicians, the BLS notes that employment is projected to grow 11% from 2018 to 2028. An increase in the aging population is expected to lead to a greater need to diagnose medical conditions, such as cancer or type 2 diabetes, through laboratory procedures.
Further, BLS states that jobs for biochemists and biophysicists are projected to grow 6% from 2018 to 2028 with more individuals needed in this field to use the knowledge they have gained from basic research to develop biological products and processes that improve lives.
This page includes information from O*NET Resource Center by the U.S. Department of Labor, Employment and Training Administration (USDOL/ETA). Used under the CC BY 4.0 license.
Given the scope and breadth of knowledge covered by this program, the acquired learning and skills will equip students to advance their career in research and drug development.
Possible careers depending on prior education, areas of expertise, and experience include:
“MSDD program has been a turning point in my professional career, which pivots around the CRO industry. The MSDD program exposed me to the myriad facets intertwined in the complex, and highly regulated field of clinical research and drug developments. Courses are structured to cover all major topics and functions covering the drug development and are taught by a thoughtful hand-picked mix of industry leaders, working professionals, and competent academicians. This allows for real-world insights into the drug development field.”
The MS in Drug Development program is typically completed in 5 semesters or 20 months if taken part-time.
For the MS Pharm Sci: Drug Development program, A grade-point average (GPA) of at least 3.00 or foreign equivalent is recommended.
Requirements include:
Please visit the Admissions Requirements page for more information.
Additional resources to support you from start to finish.
© 2024 University of Cincinnati Online Copyright Information
